Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial Academic Article uri icon

Overview

MeSH Major

  • Antifungal Agents
  • Aspergillosis
  • Salvage Therapy
  • Triazoles

abstract

  • Although the study predates extensive use of echinocandins and voriconazole, these findings demonstrate that posaconazole is an alternative to salvage therapy for patients with invasive aspergillosis who are refractory to or intolerant of previous antifungal therapy.

publication date

  • January 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1086/508774

PubMed ID

  • 17143808

Additional Document Info

start page

  • 2

end page

  • 12

volume

  • 44

number

  • 1